Several members of the American Society of Hematology (ASH) have discovered a single point mutation in the JAK2 gene that is expressed in a high percentage of patients with one of three myeloproliferative diseases. The discovery of this mutation may lead to the development of a targeted therapy to combat these disorders.

Myeloproliferative diseases (MPDs) are a closely related group of blood disorders characterized by excessive production or dysfunction of blood cells. The three main MPDs are polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. The actual incidence of MPDs is difficult to measure, but the most complete statistics to date estimate that they affect 4.7 people out of every 100,000. There is currently no known cure for MPDs.

http://cmlsupport.blogspot.com/2005/12/american-society-of-hematology.html


New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com

Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com

CML (Chronic Myelogenous Leukemia Support List)
---------------------------------
Part Of CMLHope.Com
An International Community Of CML Patients
For more information: http://cmlhope.com

Post Message: [email protected]
Subscribe:  [EMAIL PROTECTED]
Unsubscribe:  [EMAIL PROTECTED]
Change To No Mail/Web: [EMAIL PROTECTED]
Change To Digest: [EMAIL PROTECTED]
Change To Email: [EMAIL PROTECTED]
List Help: [EMAIL PROTECTED] 
CML Group Web Site http://groups.yahoo.com/group/CML




YAHOO! GROUPS LINKS




Reply via email to